Michael H. Augenbraun, MD

Dr. Augenbraun is Professor of Medicine in the College of Medicine as well as a Professor of Epidemiology in the School of Public Health. He is currently the Director of the Division of Infectious Diseases at both SUNY DS HSU as well as Kings County Hospital Center and Vice Chair for Administration of the Department of Medicine at Downstate. He completed both undergraduate and medical school education at the University of Rochester and his residency training at North Shore University Hospital. Fellowship training in infectious diseases was completed at SUNY Downstate.

For many years now, Dr. Augenbraun has also served as the Hospital Epidemiologist at University Hospital at Downstate. Dr. Augenbraun's primary focus of clinical and research interest has long been sexually transmitted infections as well as other genitourinary tract conditions. He has been involved in HIV care and research for most of his career. He has served on a consultative and advisory capacity to the NYC Department of Health and Mental Hygiene, the NYS DOH as well as the CDC. He is the author or coauthor of well over 100 references in the medical literature and has been the recipient of two SUNY Chancellor's awards.

Education and Training

• Undergraduate: University of Rochester
• Medical School: University of Rochester
• Internship: North Shore University Hospital
• Residency: North Shore University Hospital
• Fellowship: SUNY Downstate Health Sciences University

Research Interests

STDs, Syphilis, Herpes, Hepatitis C, HIV

---

Mailing Address:
SUNY Downstate College of Medicine
450 Clarkson Avenue, MSC 56
Brooklyn, New York 11203

• A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr. Clin Infect Dis. 2018 Apr 25. doi: 10.1093/cid/ciy185. [Epub ahead of print]
• Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing. Kamboj M, Brite J, Aslam A, Kennington J, Babady NE, Calfee D, Furuya Y, Chen D, Augenbraun M, Ostrowsky B, Patel G, Mircescu M, Kak V, Tuma R, Karre TA, Fry DA, Duhaney YP, Moyer A, Mitchell D, Cantu S, Hsieh C, Warren N, Martin S, Willson J, Dickman J, Knight J, Delahanty K, Flood A, Harrington J, Korenstein D, Eagan J, Sepkowitz K. Emerg Infect Dis. 2018 Mar;24(3):584-587. doi: 10.3201/eid2403.170961.
• Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, Anastos K, Augenbraun M, Fischl M, French AL, Kalapila AG, Karim R, Peters MG, Plankey M, Seaberg EC, Tien PC, Adimora AA. AIDS. 2018 Mar 13;32(5):653-661. doi: 10.1097/QAD.0000000000001745
• Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study. French AL, Martin JW, Evans CT, Peters M, Kessaye SG, Nowicki M, Kuniholm M, Golub E, Augenbraun M, Desai SN; WIHS.J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):438-444. doi: 
• Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study. Kelly EM, Dodge JL, Bacchetti P, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG.Clin Infect Dis. 2017 Nov 29;65(12):2050-2056. doi: 10.1093/cid/cix716.